KABRA DRUGS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Kabra Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-3.72₹ -0.73
As on Oct 31, 2025, 4:01 PM IST
Kabra Drugs Price Performance
Today's LowToday's High
₹18.70₹19.75
₹18.92
52 Weeks' Low52 Weeks' High
₹9.14₹22.77
₹18.92
Open Price
₹19.65
Prev. Close
₹19.65
Volume
93,534
Over the last 5 years, the share price of Kabra Drugs has gained 39.75% CAGR. Over the past year, the corresponding return has been 107.00%.
Kabra Drugs’s current P/E of -43.20x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Kabra Drugs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Kabra Drugs | 1.50 | 12.55 | -5.92 | 70.76 | 107.00 | 56.88 | 39.75 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Kabra Drugs has gained 107.00% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Kabra Drugs has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Kabra Drugs Financials
Kabra Drugs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 19.08 | 19.36 |
| 10 | 19.15 | 19.18 |
| 20 | 18.35 | 18.92 |
| 50 | 18.69 | 18.57 |
| 100 | 17.9 | 17.11 |
| 200 | 12.34 | 13.95 |
Kabra Drugs Share Holding Pattern
In the latest quarter, Kabra Drugs remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 100.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Kabra Drugs Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 14, 2025, 1:09 AM IST | Kabra Drugs Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 09, 2025, 6:30 PM IST | Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Oct 09, 2025, 12:27 AM IST | Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) |
| Oct 09, 2025, 12:26 AM IST | Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Change in Management |
| Oct 09, 2025, 12:23 AM IST | Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Change in Directorate |
About Kabra Drugs
Kabra Drugs Ltd. is a Public Limited Listed company incorporated on 22/08/1989 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L02423MP1989PLC005438 and registration number is 005438. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 23.71 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address208, Swadesh Bhavan, 2 Press Complex, AB Road, Indore Madhya Pradesh 452011
- Contact
Management
- Mr. N AravindManaging Director
- Mr. Bangalore Venkatakrishnappa Ananth KumarWholeTime Director & CFO
- Mr. Kuniamuthur Nanjappan AnandExecutive Director
- Mrs. A AnithaIndependent Director
- Mrs. Ananthkumar ShilpaIndependent Woman Director
FAQs on Kabra Drugs Share Price
What is the share price of Kabra Drugs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Kabra Drugs is ₹18.92 as on Oct 31, 2025.
What kind of stock is Kabra Drugs?
The Kabra Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Kabra Drugs?
The market cap of Kabra Drugs is ₹44.86 Cr as on Oct 31, 2025.
What are today's High and Low prices of Kabra Drugs?
Today’s highest and lowest price of Kabra Drugs are ₹19.75 and ₹18.70.
What are the 52 Week High and 52 Week Low of Kabra Drugs?
The 52-week high/low is the highest and lowest price at which Kabra Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Kabra Drugs is ₹22.77 and 52-week low of Kabra Drugs is ₹9.14 as on Oct 31, 2025.
How has the Kabra Drugs performed historically in terms of returns?
The Kabra Drugs has shown returns of -3.72% over the past day, 12.55% for the past month, -5.92% over 3 months, 107.0% over 1 year, 56.88% across 3 years, and 39.75% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Kabra Drugs?
P/E ratio of and PB ratio of Kabra Drugs are -43.20 and 1.82 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse